Data Composite

Recall D-0257-2026

US Class III Ongoing · initiated 2025-11-26

Recalling firm

SUN PHARMACEUTICAL INDUSTRIES INC, NJ

Product

Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4

Reason for recall

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

← All recalls